Shire Agrees to Buy Baxalta for $32 Billion

According to the Wall Street Journal, “Shire PLC’s six-month pursuit of peer Baxalta Inc. took a big step forward Monday when the pair announced a $32.2 billion tie-up, in one of the few ever cash-and-stock deals involving a company recently separated from its...

Shire Said in Advanced Talks to Acquire Drugmaker Baxalta

According to Bloomberg.com, “Shire Plc is in advanced talks to acquire Baxalta Inc. for about $32 billion in cash and stock, excluding debt, according to people familiar with the matter.  The two drugmakers may announce a deal as soon as this week, the people...

Pfizer, Allergan Combining in $160 Billion Deal

According to the Chicago Tribune, “Pfizer and Allergan will join in a $160 billion deal to create the world’s largest drugmaker. The transaction is valued at $363.63 per Allergan share.”  Click here for more details on this acquisition:...

Hill-Rom Acquires Welch Allyn for $2.05 Billion

FDAnews.com just announced, “Chicago, Ill.-based Hill-Rom Holdings has acquired in vitro diagnostics maker Welch Allyn for $2.05 billion.”  For more information on this merger, please visit:...